Related Experiment Video
Updated: Dec 25, 2025
09:37
A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
14.1K
The dynactin subunit DCTN1 controls osteoclastogenesis via the Cdc42/PAK2 pathway
Yong Deok Lee1, Bongjun Kim1, Suhan Jung1
1Department of Cell and Developmental Biology, BK21 Program and DRI, Seoul National University, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
Experimental & Molecular Medicine
|March 27, 2020
Summary
DCTN1 is crucial for osteoclast differentiation and bone resorption by regulating Cdc42/PAK2 signaling. Its expression must be balanced, as both deficiency and overexpression impair osteoclast formation.
Area of Science:
- Cell Biology
- Bone Biology
- Molecular Signaling
Background:
- Osteoclasts (OCs) are essential for bone resorption, differentiating from monocyte/macrophage precursors.
- RANKL signaling is a primary regulator of osteoclastogenesis.
- The dynactin complex component DCTN1's role in this process is not well understood.
Purpose of the Study:
- To investigate the role of DCTN1 in osteoclast differentiation and function.
- To elucidate the molecular mechanisms by which DCTN1 influences osteoclastogenesis.
- To assess the therapeutic potential of targeting DCTN1 in bone erosion models.
Main Methods:
- Gene knockdown of DCTN1 in precursor cells.
- Analysis of osteoclast formation, bone resorption, and transcription factor induction (NFATc1, c-Fos).
- Investigation of Cdc42 and PAK2 activation, apoptosis, and caspase-3 activity.
- Validation in an animal model of bone erosion.
Main Results:
- RANKL upregulates DCTN1 expression, which is essential for OC differentiation.
- DCTN1 knockdown inhibits OC formation, bone resorption, and key transcription factors.
- DCTN1 regulates RANKL-induced Cdc42/PAK2 activation and inhibits apoptosis.
Conclusions:
- DCTN1 is a critical regulator of osteoclastogenesis, acting via the Cdc42/PAK2 pathway and apoptosis inhibition.
- Balanced DCTN1 levels are necessary for effective osteoclast differentiation.
- Targeting DCTN1 shows potential for treating bone erosion diseases.
Related Concept Videos
00:50Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
01:22PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K
01:07MAPK Signaling Cascades
7.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
01:32Cytoskeletal Coordination in Cell Migration
5.3K
A migrating cell changes its shape during the cyclic events of attachment and detachment from the substratum and repositions the cell organelles correspondingly. These complex events are orchestrated by the dynamic cytoskeletal network comprising actin filaments, intermediate filaments, and microtubules. Cytoskeletal crosstalk — the direct and indirect communication between the different components — is crucial for this coordination. Direct communication involves various linker...
5.3K
02:15M-Cdk Drives Transition Into Mitosis
6.2K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K